25 May 2013
Keywords: Canada, Pharma investment, Rx&D, KPMG, Underreporting
Article | 21 June 2011
According to a new study by analysts at KPMG in conjunction with Canada’s pharmaceutical trade group Rx& ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
21 June 2011
24 May 2013
© 2013 thepharmaletter.com